Better Pain Management Through Better Data Act of 2018

Fact Sheet API

Bill Number

HR 5473

Introduced

Apr 11, 2018

Latest Action

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Sponsor

Cosponsors

Topics

Administrative law and regulatory procedures Consumer affairs Department of Health and Human Services Drug safety, medical device, and laboratory regulation Drug trafficking and controlled substances Health Health information and medical records Prescription drugs Public participation and lobbying

Full Text

View Full Bill Text

Votes

Summary

Better Pain Management Through Better Data Act of 2018

This bill directs the Food and Drug Administration (FDA) to update or issue guidance for drug sponsors on data collection related to the use of other pain medication to reduce the need for opioids.

The guidance must address alternative methods for data collection, product labeling, and investigations other than clinical trials.

Actions

Jun 13, 2018

Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 12, 2018

Motion to reconsider laid on the table Agreed to without objection.
Jun 12, 2018

On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5031-5032)
Jun 12, 2018

Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H5031-5032)
Jun 12, 2018

DEBATE - The House proceeded with forty minutes of debate on H.R. 5473.
Jun 12, 2018

Considered under suspension of the rules. (consideration: CR H5031-5032)
Jun 12, 2018

Mr. Walden moved to suspend the rules and pass the bill, as amended.
May 9, 2018

Ordered to be Reported by Voice Vote.
May 9, 2018

Committee Consideration and Mark-up Session Held.
Apr 11, 2018

Referred to the House Committee on Energy and Commerce.
Apr 11, 2018

Introduced in House

Amendments

Related Bills